Myocardial Effects of Aldosterone Antagonism in Heart Failure With Preserved Ejection Fraction

BACKGROUND: Spironolactone may have prognostic benefit in selected patients with heart failure with preserved ejection fraction. This study assessed the myocardial tissue effects of spironolactone in heart failure with preserved ejection fraction. METHODS AND RESULTS: A 1:1 randomized controlled stu...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Am Heart Assoc
Auteurs principaux: McDiarmid, Adam K., Swoboda, Peter P., Erhayiem, Bara, Bounford, Katrina A., Bijsterveld, Petra, Tyndall, Keith, Fent, Graham J., Garg, Pankaj, Dobson, Laura E., Musa, Tarique A., Foley, James R. J., Witte, Klaus K., Kearney, Mark T., Greenwood, John P., Plein, Sven
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2019
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6988171/
https://ncbi.nlm.nih.gov/pubmed/31852424
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.118.011521
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires